Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARMK research report →
Range $63 – $74
Price Chart
About the company
Based in Philadelphia, Pennsylvania, Aramark, established in 1959, provides a comprehensive array of services encompassing food management, facility solutions, and uniform provision. The company serves a diverse global clientele, including educational institutions, healthcare providers, various businesses and industrial clients, sports and entertainment venues, leisure operators, and correctional facilities, both within the United States and internationally. Aramark organizes its operations into three primary divisions: U.
- CEO
- John J. Zillmer
- IPO
- 2013
- Employees
- 278,390
- HQ
- Philadelphia, PA, US
AI snapshot
Six angles, distilled from the data.
The stock is in a constructive multi-month uptrend, holding above its 200-day average and trading near the upper end of its 52-week range. That keeps the regime positive, though the recent pullback from the highs shows momentum has cooled after a strong run.
Street sentiment stays constructive: consensus is Buy with a $68.64 target, above the recent close. Recent action is mostly target trimming rather than rating downgrades, with UBS cutting its target to $65 while keeping a Buy, which suggests confidence remains intact but upside expectations have narrowed.
The earnings pattern has been favorable, with three straight EPS beats and a 5-for-8 beat rate over the last eight quarters. Next year’s EPS estimate sits at 2.8089 versus 1.62 TTM, so shareholders should watch whether margin discipline and revenue growth keep supporting that step-up.
No notable discretionary insider buying or selling. Recent filings are dominated by award and in-kind activity across executives and directors, which reads more like compensation-related flow than a directional signal.
Profitability is solid but not flashy: gross margin is 8.8%, operating margin is 4.57%, and net margin is 2.16%. Growth is improving, with revenue up 4.8% year over year and earnings up 58.9%, while free cash flow of $1.41 billion and a 9.38% FCF yield support the story.
Aramark’s scale in food and facilities services gives it a defensible position, but margins remain thinner than higher-quality service peers. Valuation looks reasonable against the setup, with a 27.01 P/E versus a constructive analyst target range centered around $70.
- Market Cap
- $14.53B
- P/E
- 33.39
- Fwd P/E
- 19.95
- PEG
- 0.98
- P/S
- 0.72
- P/B
- 4.17
- EV/EBITDA
- 13.29
- Div Yield
- 0.87%
- Gross Margin
- 7.52%
- Op Margin
- 4.57%
- Net Margin
- 2.16%
- ROE
- 12.97%
- ROIC
- 6.59%
Latest fiscal year · YoY change
- Revenue
- $20.09B+8.6%
- Gross Profit
- $1.77B+65.2%
- Op Income
- $917.27M
- Net Income
- $433.71M+32.9%
- EPS
- $1.65+33.1%
- OCF Growth
- +7.4%
- FCF Growth
- +26.0%
- Beta
- 1.17
- RSI (14)
- 47
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Aramark capped fiscal 2026 with record revenue, profits, cash flow and new business, and guided fiscal 2027 to another year of solid top- and bottom-line growth.· November 16, 2026
- Fiscal 2026 revenue was $20.1 billion, with 10% organic growth; adjusted EPS was $2.23 and AOI was $1.1 billion.
- Fourth quarter adjusted EPS was $0.71, AOI was $331 million, and GAAP EPS was $0.51.
- Net new business reached a record $1.9 billion and client retention was about 97%, driving 6.8% net new business, above the 4% to 5% target.
- The board approved a new $1 billion share repurchase program and raised the quarterly dividend 17%.
- Fiscal 2027 guidance calls for 9% to 10% organic revenue growth, 15% to 19% AOI growth, 20% to 25% adjusted EPS growth, and leverage at or below 2.7x.
Aramark reported fiscal 2026 revenue of $20.1 billion, up 10% organically, with organic growth above 8% in the U.S. and 12% internationally. Adjusted operating income increased 13% on a constant-currency basis to $1.1 billion for the year, and adjusted EPS rose 21% on a constant-currency basis to $2.23. In the fourth quarter, U.S. organic revenue increased 12% to over $3.7 billion and international organic revenue increased 12% to $1.6 billion. Fourth-quarter adjusted operating income was $331 million, adjusted EPS was $0.71, GAAP operating income was $264 million, and GAAP EPS was $0.51. Free cash flow for fiscal 2026 was $573 million, net cash from operating activities was $989 million, and leverage ended at 2.7x. For fiscal 2027, the company guided to 9% to 10% organic revenue growth, 15% to 19% AOI growth, 20% to 25% adjusted EPS growth, and leverage at or below 2.7x.
John Zillmer described fiscal 2026 as a "phenomenal" and "extraordinary" year, emphasizing broad-based double-digit growth, record gross new client wins, and all-time high retention. He framed the business as entering fiscal 2027 with strong momentum across the total portfolio, not just Nexus, and pointed to continued runway in collegiate hospitality, healthcare, workplace, sports and entertainment, and international. He was upbeat but careful on Nexus, saying the company is moving "full speed ahead" while being prudent about timing and regulatory issues.
Jim Tarangelo said fiscal 2026 delivered broad-based 10% organic revenue growth, expanded margins, and record free cash flow. He highlighted AOI of $1.1 billion, AOI margin expansion of 25 basis points, adjusted EPS of $2.23, free cash flow of $573 million, and leverage improvement to 2.7x after reducing net debt by $225 million. He also noted that fourth-quarter incentive-based cash and equity compensation charges were about $26 million, that the company expects around 30 to 40 basis points of margin expansion in fiscal 2027 at the midpoint of guidance, and that the higher dividend and $1 billion buyback reflect the balance sheet and cash generation.
Analysts pressed management on Nexus timing, visibility, and how much of the $500 million expected fiscal 2027 Nexus revenue is already embedded in the $1.9 billion of gross new business. Management said about $300 million of that $1.9 billion is related to Nexus, that the two hyperscaler sites should drive more than $150 million of annualized revenue each, and that the $500 million is expected to be realized in year, with additional opportunities like workforce housing and colocation expected later. Questions also focused on whether incentive comp would pressure margins again; management said the compensation charges are already baked into guidance. On retention and growth, management said 97% retention was clean and record-level, while the 9% to 10% growth outlook reflects strong base business, pricing, and about 6% net new contribution.
The call showed a business firing on multiple cylinders: record new wins, record retention, double-digit organic growth, and record free cash flow. Management sounded confident that Nexus, broad pipeline strength, and international momentum can sustain above-historical growth into fiscal 2027, while the balance sheet gives flexibility for buybacks and dividends.
The main risk is execution and timing on Nexus, since management said the fiscal 2027 contribution depends on the ramp of current sites and future opportunities, and the company acknowledged some revenue timing uncertainty. Management also flagged external sensitivities such as regulatory conditions around data centers, potential MLB disruption, and the fact that parts of growth and margin expansion depend on continued strong retention, supply chain economics, and favorable operating conditions.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.2%
- Shares Outstanding
- 263.63M
- Float Shares
- 261.51M
of shares held by institutions
564 13F filers
Buy/sell ratio 0.62. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ARMK, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Michael T. McCaulHouse · TX10 | Sell | Jun 18, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Dec 10, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Buy | Jun 11, 25 | Filing → |
| Lisa C. McClainHouse · MI09 | Sell | Jun 17, 25 | Filing → |
| Jonathan JacksonHouse · IL01 | Sell | Apr 10, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Apr 14, 25 | Filing → |
| William R. KeatingHouse · MA09 | Buy | Feb 5, 25 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Nov 14, 24 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Sep 20, 24 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Sep 20, 24 | Filing → |
| Jonathan JacksonHouse · IL01 | Buy | Sep 19, 24 | Filing → |
| William R. KeatingHouse · MA09 | Buy | Mar 17, 21 | Filing → |
| Susie LeeHouse · NV03 | Sell | Aug 4, 20 | Filing → |
| Susie LeeHouse · NV03 | Buy | Apr 27, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 25.32M | ▲ 510.77K |
| Vanguard Group Inc | 24.63M | ▼ 278.28K |
| Jupiter Topco LLC | 18.30M | ▲ 18.30M |
| Janus Henderson Group Ltd. | 17.10M | ▲ 17.10M |
| Massachusetts Financial Services Co | 14.71M | ▼ 862.44K |
| Capital International Investors | 11.91M | ▲ 1.99M |
| Vanguard Capital Management LLC | 11.84M | ▼ 20.73K |
| Morgan Stanley | 11.70M | ▼ 205.15K |
| Vanguard Portfolio Management LLC | 11.17M | ▼ 9.87K |
| Aqr Capital Management LLC | 9.25M | ▲ 1.10M |
| State Street Corp | 8.30M | ▲ 112.06K |
| Fiduciary Management Inc | 6.31M | ▼ 208.92K |
Held by 600 ETFs
Biggest fund positions in ARMK by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 18, 26 | Schilling Christopher T. | other | 445.486 |
| Nov 18, 26 | Charpentier Abigail | other | 661.635 |
| Nov 18, 26 | Harrington Lauren A | other | 1,147.231 |
| Nov 18, 26 | Bruno Marc A | other | 1,528.511 |
| Nov 18, 26 | Tarangelo James J. | other | 682.881 |
| Nov 18, 26 | ZILLMER JOHN J | other | 7,850.547 |
| Nov 9, 26 | Tarangelo James J. | other | 39,841 |
| Nov 9, 26 | ZILLMER JOHN J | other | 245,272 |
| Nov 9, 26 | Schilling Christopher T. | other | 6,198 |
| Nov 9, 26 | Harrington Lauren A | other | 45,183 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ARMK coverage
Recent articles, reports, and earnings notes.

Aramark Holdings (ARMK): Nexus Growth Meets Leverage Risk
Aramark is growing quickly, with 9.0% Q3 revenue growth, a raised 2026 organic outlook, and more than $1.6B in new business wins. The stock looks attractive on forward earnings, but debt remains the key risk.

Aramark's earnings beat is making the boring-stock thesis investable
Aramark is turning steady service revenue into faster profit growth, and the latest earnings reaction shows the market is starting to believe the pattern is repeatable. The valuation is no longer sleepy, but the operating leverage and deleveraging roadmap justify a bullish stance.

Aramark (ARMK) rises 8.6% after strong Q3 earnings beat
Aramark (ARMK) rises after reporting a strong fiscal third quarter, with adjusted EPS beating estimates and revenue growth accelerating. The stock moved above its 52-week high on heavy volume as investors reacted to improving margins, strong client retention, and robust new-business wins.
Want a deeper read on ARMK?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
AI analysis · Last refreshed November 20, 2026 · Live quote · Not investment advice